MCID: ALG001
MIFTS: 38

Algoneurodystrophy

Categories: Neuronal diseases

Aliases & Classifications for Algoneurodystrophy

MalaCards integrated aliases for Algoneurodystrophy:

Name: Algoneurodystrophy 12 15 71 32
Reflex Sympathetic Dystrophy 71

Classifications:



External Ids:

Disease Ontology 12 DOID:14022
ICD9CM 34 733.7
SNOMED-CT 67 203490000
ICD10 32 M89.0
UMLS 71 C0034931 C0205930

Summaries for Algoneurodystrophy

MalaCards based summary : Algoneurodystrophy, also known as reflex sympathetic dystrophy, is related to reflex sympathetic dystrophy and carpal tunnel syndrome. An important gene associated with Algoneurodystrophy is LCAT (Lecithin-Cholesterol Acyltransferase), and among its related pathways/superpathways are Neuroscience and Regulation of lipolysis in adipocytes. The drugs Lidocaine and Gabapentin have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, bone and skin.

Wikipedia : 74 Complex regional pain syndrome (CRPS), also known as reflex sympathetic dystrophy (RSD), describes an... more...

Related Diseases for Algoneurodystrophy

Diseases related to Algoneurodystrophy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 92)
# Related Disease Score Top Affiliating Genes
1 reflex sympathetic dystrophy 30.3 TAC1 KNG1 CALCA
2 carpal tunnel syndrome 29.6 TAC1 INS
3 carbamazepine allergy 10.2 TAC1 CALCA
4 taylor's syndrome 10.1 TAC1 CALCA
5 plantar fasciitis 10.1 TAC1 CALCA
6 epicondylitis 10.1 TAC1 CALCA
7 prurigo nodularis 10.1 TAC1 NGF
8 punctate epithelial keratoconjunctivitis 10.1 TAC1 NGF
9 femoral cancer 10.1 TAC1 NGF
10 kwashiorkor 10.1 LCAT INS
11 ileus 10.1 INS CALCA
12 monocarboxylate transporter 1 deficiency 10.1 LCAT INS
13 fetal macrosomia 10.1 LCAT INS
14 ventricular fibrillation, paroxysmal familial, 1 10.1 NGF KNG1
15 mononeuropathy 10.1 TAC1 NGF
16 neuropathy, hereditary sensory and autonomic, type iii 10.1 NGF DBH
17 corneal ulcer 10.1 TAC1 NGF
18 suppurative thyroiditis 10.1 INS CALCA
19 graves disease 1 10.0 INS CALCA
20 interval angle-closure glaucoma 10.0 TAC1 KNG1
21 complex regional pain syndrome 10.0 TAC1 CALCA
22 neurotic disorder 10.0 NGF INS
23 somatostatinoma 10.0 INS CALCA
24 diabetic encephalopathy 10.0 NGF INS
25 intracranial vasospasm 10.0 TAC1 KNG1
26 acute apical periodontitis 10.0 TAC1 KNG1
27 coronary heart disease 1 10.0 LCAT INS
28 akinetopsia 10.0 TAC1 KNG1
29 diabetic autonomic neuropathy 10.0 NGF INS
30 neurogenic bladder 10.0 TAC1 NGF
31 chronic ulcer of skin 10.0 NGF INS
32 urethral syndrome 10.0 TAC1 NGF
33 renal hypertension 10.0 KNG1 DBH
34 paralytic ileus 10.0 TAC1 INS
35 transient refractive change 10.0 TAC1 INS
36 cocaine abuse 10.0 NGF DBH
37 parathyroid gland disease 10.0 INS CALCA
38 functional gastric disease 10.0 TAC1 INS
39 meningoencephalitis 10.0 TAC1 NGF
40 mineral metabolism disease 9.9 INS CALCA
41 aspiration pneumonia 9.9 TAC1 INS
42 causalgia 9.9 TAC1 NGF CALCA
43 detrusor sphincter dyssynergia 9.9 TAC1 NGF CALCA
44 corneal disease 9.9 TAC1 NGF LCAT
45 burning mouth syndrome 9.9 TAC1 NGF CALCA
46 somatoform disorder 9.9 TAC1 NGF CALCA
47 angina pectoris 9.9 KNG1 INS
48 raynaud disease 9.9
49 osteomalacia 9.9
50 herpes zoster 9.9

Comorbidity relations with Algoneurodystrophy via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Algoneurodystrophy:



Diseases related to Algoneurodystrophy

Symptoms & Phenotypes for Algoneurodystrophy

Drugs & Therapeutics for Algoneurodystrophy

Drugs for Algoneurodystrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 107)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
2
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
3
Benzocaine Approved, Investigational Phase 4 1994-09-7, 94-09-7 2337
4
tannic acid Approved Phase 4 1401-55-4
5
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
6
Bupivacaine Approved, Investigational Phase 4 38396-39-3, 2180-92-9 2474
7 Anesthetics, Local Phase 4
8 Sodium Channel Blockers Phase 4
9 Neurotransmitter Agents Phase 4
10 Excitatory Amino Acid Antagonists Phase 4
11 Diuretics, Potassium Sparing Phase 4
12 Anti-Arrhythmia Agents Phase 4
13 Anti-Inflammatory Agents Phase 4
14 Pharmaceutical Solutions Phase 4
15 Triamcinolone hexacetonide Phase 4
16 triamcinolone acetonide Phase 4
17 Triamcinolone diacetate Phase 4
18 Immunologic Factors Phase 4
19 Hormone Antagonists Phase 4
20 Immunosuppressive Agents Phase 4
21 glucocorticoids Phase 4
22 potassium phosphate Phase 4
23
Levobupivacaine Approved, Investigational Phase 3 27262-47-1 92253
24
Ropivacaine Approved Phase 3 84057-95-4 71273 175805
25
Zoledronic Acid Approved Phase 3 118072-93-8 68740
26
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
27
Nitrous oxide Approved, Vet_approved Phase 3 10024-97-2 948
28
Vitamin C Approved, Nutraceutical Phase 3 50-81-7 5785 54670067
29
Imidacloprid Vet_approved Phase 3 105827-78-9 86418
30 Diphosphonates Phase 3
31 Immunoglobulins Phase 3
32 gamma-Globulins Phase 3
33 Antibodies Phase 3
34 Immunoglobulins, Intravenous Phase 3
35 Rho(D) Immune Globulin Phase 3
36 Anesthetics, Intravenous Phase 3
37 Nutrients Phase 3
38 Micronutrients Phase 3
39 Trace Elements Phase 3
40 Vitamins Phase 3
41 Antioxidants Phase 3
42 Protective Agents Phase 3
43 Analgesics, Non-Narcotic Phase 3
44 Anesthetics Phase 3
45 Anesthetics, General Phase 3
46 Anesthetics, Inhalation Phase 3
47
Dronabinol Approved, Illicit Phase 2 1972-08-3 16078
48
Midazolam Approved, Illicit Phase 2 59467-70-8 4192
49
Cetuximab Approved Phase 2 205923-56-4 56842117 2333
50
Ketamine Approved, Vet_approved Phase 2 6740-88-1 3821

Interventional clinical trials:

(show top 50) (show all 118)
# Name Status NCT ID Phase Drugs
1 Prophylactic Administration of Vitamin C in Wrist Fractures; a Randomized Placebo Controlled Multicentre Dose-Finding Study of the Incidence of Complex Regional Pain Syndrome Completed NCT00296868 Phase 4 ascorbic acid (vitamin C) versus placebo
2 Assessing the Tolerability of Suprascapular and Median Nerve Blocks for the Treatment of Shoulder-hand Syndrome - a Feasibility Study Completed NCT03291197 Phase 4 Suprascapular and median nerve blocks
3 Restore Claims Characterization Study Completed NCT00200122 Phase 4
4 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions Completed NCT00904202 Phase 4 Placebo Capsules + Placebo Patch;Placebo capsules + Lidoderm®;Gabapentin + Placebo;Gabapentin + Lidoderm®;Gabapentin 300 mg capsules 1800 mg/day + placebo patch;Gabapentin 1800 mg/day + Lidoderm patch
5 Single Blinded, Randomized Control Trial of High Frequency Stimulation in Subjects With Precision® Spinal Cord Stimulator System to Assess Efficacy and Preferability in Back and Extremity Pain Relief Completed NCT02265848 Phase 4
6 Peripheral Nerve Injections for the Treatment of Upper Extremity Complex Regional Pain Syndrome: A Feasibility Study for a Proposed Randomized Design Not yet recruiting NCT04744675 Phase 4 Triamcinolone Acetonide 40mg/mL;Saline Injection
7 Surgical Treatment of Complex Regional Pain Syndrome Type II (CRPS II) by Regional Subcutaneous Venous Sympathectomy Unknown status NCT01392599 Phase 3
8 An Analysis of Photoplethysmographic Signal in Diagnostic Lumbar Sympathetic Block for Complex Regional Pain Syndrome Unknown status NCT01134289 Phase 3
9 Acupuncture and Traditional Chinese Medicine Combined With Rehabilitation Therapy for Post-stroke Shoulder-hand Syndrome in Community Hospital: a Multicenter,Randomized,Controlled Trial Unknown status NCT02011854 Phase 2, Phase 3
10 CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I) Unknown status NCT02504008 Phase 3 AXS-02 (oral zoledronate);Placebo
11 Prospective, Double-blind, Randomised, Placebo-controlled, Cross-over Study to Investigate the Effect of Intravenous Immunoglobulins on Complex Regional Pain Syndrome (CRPS, M. Sudeck) Unknown status NCT00949065 Phase 3
12 Double-Blind Randomized Controlled Trial: Thoracic Sympathetic Block for the Treatment of Complex Regional Pain Syndrome I of the Upper Limb Unknown status NCT01612364 Phase 3
13 Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidamide in the Treatment of Complex Regional Pain Syndrome Type1 Completed NCT00166452 Phase 3 Lenalidamide
14 A Randomized, Double-blind Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome Type I (CRPS-I) Completed NCT02402530 Phase 2, Phase 3 Placebo;Neridronic acid 62.5 mg
15 A Verification Study of JNS020QD in Patients With Post-herpetic Neuralgia, Complex Regional Pain Syndrome (CRPS) or Postoperative Pain Syndrome Completed NCT01008553 Phase 3 Fentanyl;Placebo
16 Pain Exposure Physical Therapy Or Conservative Therapy for Patients With Complex Regional Pain Syndrome Type I Completed NCT00817128 Phase 2, Phase 3
17 Open-label Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS) Completed NCT02972359 Phase 3 Neridronic acid
18 Role of Vitamin C at 6 Months on Incidence of Complex Regional Pain Syndrome Type I in Upper Limb Surgery Recruiting NCT02390505 Phase 3 Vitamin C;Placebo
19 A Prospective Randomized Controlled Pilot Study Nitrous Oxide for the Treatment of Complex Regional Pain Syndrome Enrolling by invitation NCT03879538 Phase 3 Nitrous Oxide;Oxygen
20 Pilot Study to Evaluate the Effectiveness of a Mixture of Ketamine / Lidocaine Administered by Mesotherapy in the Management of Neuropathic Pain in Complex Regional Pain Syndrome Type 1 (CRPS1). A Monocentric Randomized and Controlled Clinical Study Not yet recruiting NCT04650074 Phase 2, Phase 3 LIDOCAINE 20 mg;LIDOCAINE 20 mg + KETAMINE 20 mg;LIDOCAINE 20 mg + KETAMINE 40 mg
21 Placebo-controlled Efficacy and Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS) Terminated NCT03560986 Phase 3 Neridronic acid 100 mg;Placebo
22 Randomized, Double-blind, Placebo-controlled Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS) Terminated NCT03530345 Phase 3 Neridronic acid 100 mg;Placebo
23 Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception Withdrawn NCT00349050 Phase 2, Phase 3
24 Low Dose Administration of Delta9-Tetrahydrocannabinol for the Prevention of Hyperalgesia and Chronic Pain in Patients With Acute Complex Regional Pain Syndrome (CRPS) of the Upper Limb Unknown status NCT00377468 Phase 2 Delta9-Tetrahydrocannabinol
25 Phase 2 Study - The Use of a Single 5 mg Dose of Zoledronic Acid in Complex Regional Pain Syndrome Patient. Unknown status NCT01788176 Phase 2 Zoledronic acid;Placebo
26 Double Blind Placebo Controlled Study of Outpatient Intravenous Ketamine for the Treatment of CRPS Completed NCT00579085 Phase 2 Ketamine
27 A Multicenter, Open-Label Study to Evaluate the Preliminary Safety and Efficacy of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS) Completed NCT00067743 Phase 2 Lenalidomide
28 CCRC: The Analgesic Effect of Vaporized Cannabis on Neuropathic Pain Completed NCT01037088 Phase 1, Phase 2 Mild dose cannabis;Low dose cannabis;Cannabis
29 A Randomized, Cross-over, Placebo-controlled, Double-blind, Single-center, Phase II Study of Cetuximab in Patients With Treatment-refractory, Non-malignant Severe Chronic Neuropathic Pain Completed NCT02490436 Phase 2 Cetuximab;Placebo
30 A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 as an Adjunctive Therapy in Adult Subjects With Chronic Complex Regional Pain Syndrome Completed NCT03990649 Phase 2 TAK-935;TAK-935 Placebo
31 Use of Autologous Adult Adipose-Derived Stem/Stromal Cells in Reflex Sympathetic Dystrophy (RSD), Complex Regional Pain Syndrome (CRPS), and Fibromyalgia Enrolling by invitation NCT02987855 Phase 1, Phase 2
32 Randomized Controlled Trial of Subanesthetic Intravenous Ketamine Infusion in Conjunction With Continuous Epidural Infusion for Treatment of Refractory Complex Regional Pain Syndrome Terminated NCT02094352 Phase 2 Ketamine Infusion + Epidural Infusion;Control Group + Epidural infusion;Ketamine Booster Infusion;Control Group Booster Infusion
33 Neurotropin for Acute Dental Pain and for Chronic Neuropathic Pain Terminated NCT00006289 Phase 2 Placebo;Neurotropin
34 A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1 Terminated NCT00109772 Phase 2 lenalidomide;Placebo
35 A Single Centre. Parallel-Group, Double-Blinded, Randomized, Placebo-Controlled Pilot Clinical Trial on Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Terminated NCT00689585 Phase 2 Placebo;Ethosuximide
36 Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain. Terminated NCT02321566 Phase 1
37 Comparison of the Efficacy of the Ultrasound With Fluoroscopy in Guidance of Lumbar Sympathetic Block: A Prospective Randomized Open-label Trial Unknown status NCT02737527 10 ml of 0.25% levobupivacaine injection for LSB
38 Effects of Repetitive Electric Sensory Stimulation on Sensorimotor Performance and Pain Intensity in Complex Regional Pain Syndrome Type I Unknown status NCT01915329
39 Comparison of Two Measures of Tactile Acuity in CRPS Type I Patients , Patients With a Neuropathy of the Median Nerve and Healthy Controls. Unknown status NCT01888783
40 Comparison of Gait Parameters Between Floor and Sponge Surfaces and Special Shoes in Individuals With Difficulties in Weight-bearing Unknown status NCT02742376
41 The Effect of Vitamin c on Preventing Complex Regional Pain Syndrome (CRPS Type I) Following Ankle Fracture, Prospective Double Blind Study Unknown status NCT01338129 placebo
42 Effects of Proprioceptive Stimulation Under Visual Feedback in Patient With CRPS: An Exploratory Study Unknown status NCT02395211
43 Identifying Markers of Trajectory in Pediatric Complex Regional Pain Syndrome Unknown status NCT03838107
44 "Efficacy of Botulinum Toxin Injection in Reducing Limb Pain in Patients With Complex Regional Pain Syndrome" Unknown status NCT03616262 Early Phase 1 Botox + Lidocaine;Lidocaine alone
45 Effects of Pennsaid on Clinical Neuropathic Pain Completed NCT01508676 Pennsaid;Placebo (2.3% DMSO solution)
46 Investigation of the Efficacy of Transcranial Direct Current Stimulation (tDCS) Added to the Graded Motor Imagery (GMI) in the Treatment of Complex Regional Pain Syndrome (CRPS) Type 1 Completed NCT01960400
47 Near-infrared Spectroscopic Measurement of Tissue Oxygen Saturation and the Vascular Occlusion Test in Complex Regional Pain Syndrome Completed NCT01586377
48 Changes in Skin Conductance Measurement as an Endpoint Monitor for Sympathetic Blocks Completed NCT02390323
49 Transcranial Magnetic Stimulation for CRPS Completed NCT02067273
50 Evaluation of Autonomic Cardiac Function in Patients With Complex Regional Pain Syndrome Completed NCT00560131

Search NIH Clinical Center for Algoneurodystrophy

Genetic Tests for Algoneurodystrophy

Anatomical Context for Algoneurodystrophy

MalaCards organs/tissues related to Algoneurodystrophy:

40
Spinal Cord, Bone, Skin, Cortex, Dorsal Root Ganglion, Bone Marrow, Breast

Publications for Algoneurodystrophy

Articles related to Algoneurodystrophy:

(show top 50) (show all 1666)
# Title Authors PMID Year
1
Prospective randomized study of the vitamin C effect on pain and complex pain regional syndrome after total knee arthroplasty. 61
33438072 2021
2
Extensor Retinaculum Flap and Fibular Periosteum Ligamentoplasty After Failed Surgery for Chronic Lateral Ankle Instability. 61
32755269 2020
3
Anesthetic Management of a Complex Regional Pain Syndrome (CRPS) Patient With Ketamine. 61
33393601 2020
4
Complex Regional Pain Syndrome Caused by an Axillary Lipoma. 61
33510987 2020
5
Direct Peripheral Nerve Stimulation for the Treatment of Complex Regional Pain Syndrome: A 30-Year Review. 61
33098229 2020
6
Injury mechanisms of ankle fractures with dislocation and analysis of differences on functional outcome. 61
32946097 2020
7
Outcome after the surgical treatment of the Dubberley type B distal humeral capitellar and trochlear fractures with a buttress plate. 61
32554364 2020
8
[Zheng's massage combined with electroacupuncture in the treatment of reflex sympathetic dystrophy syndrome of the wrist]. 61
32573159 2020
9
The role of trauma mechanism, fracture pattern and fixation technique on clinical outcomes and epiphyseal growth arrest in the surgical treatment of distal tibial epiphysiolysis. 61
32436969 2020
10
Economic evaluations of physiotherapy interventions for neurological disorders: a systematic review. 61
30616401 2020
11
A Paradigm Shift in Managing Acute and Chronic Boutonniere Deformity: Anatomic Rationale and Early Clinical Results for the Relative Motion Concept Permitting Immediate Active Motion and Hand Use. 61
32028337 2020
12
Peripheral Neuropathic Pain and Pain Related to Complex Regional Pain Syndrome with and without Fixed Dystonia - Efficient Therapeutic Approach with Local Anesthetics. 61
32099453 2020
13
Cervicogenic exophthalmos: Possible etiology and pathogenesis. 61
32047780 2020
14
Associations of PTSD, chronic pain, and their comorbidity on cannabis use disorder: Results from an American nationally representative study. 61
31356731 2019
15
[Calcitonin as an analgesic agent: review of mechanisms of action and clinical applications]. 61
31810524 2019
16
The application of dual-energy computed tomography in the diagnosis of musculoskeletal disorders: a review of current concepts and applications. 61
30828774 2019
17
Reflex Sympathetic Dystrophy of the Right Hand following an Acute Traumatic Injury. 61
31608198 2019
18
Electroacupuncture for Reflex Sympathetic Dystrophy after Stroke: A Meta-Analysis. 61
30826129 2019
19
Ozone Therapy for Complex Regional Pain Syndrome: Review and Case Report. 61
31062104 2019
20
Complex regional pain syndrome - False hopes and miscommunications. 61
30639650 2019
21
[Mid-term results in the treatment of osteochondritis dissecans of the femoral condyles using osteochondral grafting (mosaic arthroplasty)]. 61
31312303 2019
22
Posttraumatic stress disorder and chronic pain are associated with opioid use disorder: Results from a 2012-2013 American nationally representative survey. 61
29775955 2018
23
Approach to the Patient with Disproportionate Pain. 61
29799372 2018
24
Complex Regional Pain Syndrome: What the Dermatologist Should Know. 61
29742184 2018
25
Mini-plate fixation via sinus tarsi approach is superior to cannulated screw in intra-articular calcaneal fractures: A prospective randomized study. 61
30101667 2018
26
Living With Chronic Pain. 61
29669658 2018
27
How a Simple Ankle Sprain Turned Into Neuropathic Pain: Complex Reflex Sympathetic Dystrophy Versus Erythromelalgia. 61
29121832 2018
28
Operative versus nonoperative treatment of displaced intra-articular calcaneal fractures: A meta-analysis of current evidence base. 61
29245290 2017
29
Outcomes Following Isolated Posterior Interosseous Nerve Neurectomy: A Systematic Review. 61
28720049 2017
30
[Reflex sympathetic dystrophy involving the ankle and the foot in a particular pathological pregnancy: Exceptional association]. 61
28919273 2017
31
Bone SPECT/CT Localizes Increased Bone Metabolism and Subsequent Bone Resorption in Reflex Sympathetic Dystrophy. 61
28806248 2017
32
Efficacy of vitamin C in preventing complex regional pain syndrome after wrist fracture: A systematic review and meta-analysis. 61
28274883 2017
33
A Comprehensive Outcome-Specific Review of the Use of Spinal Cord Stimulation for Complex Regional Pain Syndrome. 61
27739179 2017
34
Quantitative determination of methamphetamine in oral fluid by liquid-liquid extraction and gas chromatography/mass spectrometry. 61
27022165 2017
35
The Unexpected Hand Patient. 61
28536645 2017
36
Calcineurin Inhibitor-Induced Pain Syndrome in ABO-Incompatible Living Kidney Transplantation: A Case Report. 61
28104127 2017
37
[Spinal cord stimulation in 62 patients: Retrospective evaluation]. 61
28467566 2017
38
[How I treat? complex regional pain syndrome]. 61
28387091 2016
39
Putative Physiopathological Explanation for the "Sock Sign" in Bone Scans. 61
27187731 2016
40
Tibiotalocalcaneal arthrodesis by using proximal humeral locking plate. 61
27519965 2016
41
Successful Treatment of Complex Regional Pain Syndrome with Pseudoaneurysm Excision and Median Nerve Neurolysis. 61
27318309 2016
42
Late Spontaneous Migration of a Dorsal Column Stimulator Paddle Lead. 61
27672531 2016
43
Complex regional pain syndrome and dysautonomia in a 14-year-old girl responsive to therapeutic plasma exchange. 61
26011726 2016
44
Steroid atrophy scarring treated with fat grafting in a patient with complex regional pain syndrome: A case report. 61
26735938 2016
45
The Relation Between Reflex Sympathetic Dystrophy Syndrome and Trauma Severity in Patients With Distal Tibia Fracture. 61
27626009 2016
46
Imaging in Foot and Ankle Arthritis. 61
27336451 2016
47
Operative Versus Nonoperative Treatment of Displaced Intra-Articular Calcaneal Fractures: A Meta-Analysis of Randomized Controlled Trials. 61
26371619 2016
48
Intratendinous rupture of the supraspinatus: anatomical and functional results of 24 operative cases. 61
26521196 2016
49
Mania following ketamine abuse. 61
26869791 2016
50
Management of Urinary and Fecal Incontinence in Patients With Complex Regional Pain Syndrome. 61
26516817 2016

Variations for Algoneurodystrophy

Expression for Algoneurodystrophy

Search GEO for disease gene expression data for Algoneurodystrophy.

Pathways for Algoneurodystrophy

Pathways related to Algoneurodystrophy according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.46 PTGS1 NGF DBH CALCA
2 10.71 PTGS1 INS

GO Terms for Algoneurodystrophy

Cellular components related to Algoneurodystrophy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.5 TAC1 NGF LCAT KNG1 INS DBH
2 extracellular space GO:0005615 9.17 TAC1 NGF LCAT KNG1 INS DBH
3 endosome lumen GO:0031904 9.16 NGF INS

Biological processes related to Algoneurodystrophy according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 cell-cell signaling GO:0007267 9.65 TAC1 INS CALCA
2 cellular protein metabolic process GO:0044267 9.63 KNG1 INS CALCA
3 cellular response to nerve growth factor stimulus GO:1990090 9.49 TAC1 CALCA
4 inflammatory response GO:0006954 9.46 TAC1 PTGS1 KNG1 CALCA
5 associative learning GO:0008306 9.43 TAC1 DBH
6 positive regulation of cytosolic calcium ion concentration GO:0007204 9.43 TAC1 KNG1 CALCA
7 negative regulation of proteolysis GO:0045861 9.4 KNG1 INS
8 vasodilation GO:0042311 9.37 KNG1 CALCA
9 positive regulation of blood vessel diameter GO:0097755 9.32 INS CALCA
10 regulation of blood pressure GO:0008217 9.13 TAC1 PTGS1 CALCA
11 response to pain GO:0048265 8.8 TAC1 DBH CALCA

Sources for Algoneurodystrophy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....